UCLA performs first hand transplant in the western United States
Patient hopes procedure will enhance her ability to care for her daughter
By Roxanne Moster March 07, 2011 Category: Health Sciences
(Editors: Video b-roll and still photographs of the surgery are available upon request.)
Surgeons at Ronald Reagan UCLA Medical Center performed the first hand transplant in the western United States in an operation that began one minute before midnight on Friday, March 4, and was completed 14-and-a-half hours later, on Saturday, March 5.
The transplant was performed on a 26-year-old mother from Northern California who lost her right hand in a traffic accident nearly five years ago. UCLA is only the fourth center in the nation to offer this procedure, and the first west of the Rockies. This was the 13th hand transplant surgery performed in the United States.
A team of 17 surgeons, anesthesiologists, operating room nurses and technicians were involved in the effort to graft the hand onto the patient. The operation began with two surgical teams working simultaneously to prepare the donor graft and the recipient. At 4:30 a.m. on Saturday, four-and-a-half hours after the operation began, the donor limb was joined to the recipient. The surgeons then began the complex work of attaching tendons, blood vessels and nerves to complete the surgery, which concluded at 2:30 p.m.
Following the surgery, the patient was brought back to her room, where she was met by grateful members of her family. She remains at the medical center and will begin extensive physical rehabilitation and a regimen of immunosuppressant medication to help prevent her body from rejecting the new appendage.
"I am ecstatic with the results — a little tired, but ecstatic," said lead surgeon Dr. Kodi Azari, surgical director of the UCLA Hand Transplant Program and associate professor of orthopaedic surgery and plastic surgery at the David Geffen School of Medicine at UCLA, at the conclusion of the marathon surgery. "Everything went well. The size, color and hair pattern match between the donor and recipient is nearly identical. We are so proud to have been able to give our patient the gift of a new hand."
Azari was a surgeon in four previous hand transplant surgeries performed in the U.S. prior to coming to UCLA.
The transplant was made possible by the generosity of the family of a deceased donor in San Diego. The donor's family worked with the staff at Lifesharing, who had been briefed last week by the transplant team at UCLA. Lifesharing, a division of UC San Diego Medical Center, is a nonprofit, federally designated organ and tissue recovery organization serving San Diego and Imperial counties.
The transplant surgery is part of a clinical trial at UCLA intended to confirm that surgical techniques already established in hand transplantation are successful. The trial also aims to study the return of function in transplanted hands and to assess the effectiveness and safety of a less toxic anti-rejection medication protocol.
The transplant team will closely monitor the patient's progress and how well her body adjusts to the new hand. As part of this, doctors will map her brain at key points in her recovery, observing which parts light up when she is asked to move her fingers or other parts of the new hand.
"This surgery is part of the UCLA tradition of excellence in transplantation, and this is clearly a landmark event," said Dr. Ronald Busuttil, executive chair of the UCLA Department of Surgery, chief of the division of liver and pancreas transplantation, and a groundbreaking transplant surgeon who 27 years ago established the world-renowned UCLA Liver Transplant Program. "We now are the first center in the western United States to be performing composite-tissue transplantation. Everything necessary for this procedure has been aligned perfectly, with outstanding planning and teamwork. It has come together beautifully."
The UCLA Hand Transplant Program is aimed at helping those who have suffered the traumatic loss of a hand or forearm, allowing them to regain function and improve their quality of life. It is a partnership between UCLA's transplantation services and its hand surgery, plastic and reconstructive surgery, orthopaedic surgery, psychiatry, pathology, anesthesia, internal medicine, radiology, neurology, ethics and rehabilitation services.
Eligibility criteria for the hand transplantation study include:
- The patient must be between 18 and 60 years of age.
- The amputation must have been at the wrist or at the forearm level.
- The patient must have no serious infections, including hepatitis B or C, or HIV.
- The amputation was not due to a birth defect or cancer.
- The patient is otherwise in good general health.
- The patient will commit to extensive rehabilitation, will adhere to an immunosuppressant medication regimen, and will participate in follow-ups with the transplant center.
Patients interested in participating first have to undergo a careful evaluation to determine if they meet the conditions for participation in the program. The evaluation includes taking a detailed medical history, a physical examination and lab tests, X-ray tests, and a psychological examination.
After successfully completing a screening and medical evaluation, the patient is placed on a waiting list until a carefully matched hand from a deceased donor is found. After the transplant surgery, the patient will take immunosuppressive medicines for an indefinite amount of time to prevent rejection. Patients will also undergo an intensive rehabilitation regimen to restore function to the transplanted hand.
Lifesharing is one of four federally designated organ recovery organizations serving the state of California. Collectively known as Donate Life California, these nonprofit organizations administer the state's official pink dot Donate Life California Registry. As of early March 2011, more than 8 million Californians had signed up at the Department of Motor Vehicles or online at www.donatelifecalifornia.org to be organ and tissue donors after they are deceased. The Donate Life California Organ and Tissue Donor Registry is now the largest in the nation, which is critical because California has the largest number of people on the U.S. waiting list.
The David Geffen School of Medicine at UCLA ranks among the nation's elite medical schools, producing doctors and researchers whose contributions have led to major breakthroughs in health care. With more than 2,000 full-time faculty members, nearly 1,300 residents, more than 750 medical students and almost 400 Ph.D. candidates, the medical school is ranked seventh in the country in research funding from the National Institutes of Health and third in the United States in research dollars from all sources.
The UCLA Health System, which comprises the UCLA Hospital System and the UCLA Medical Group and its affiliates, has provided the best in health care and the most advanced treatment options to the people of Los Angeles and the world for more than half a century. UCLA's preeminence in health care — a strength that comes from the union of research, teaching and excellence in patient care — continues to be recognized nationally, internationally and in numerous forums. The clinical programs of Ronald Reagan UCLA Medical Center, Santa Monica–UCLA Medical Center and Orthopaedic Hospital, the Resnick Neuropsychiatric Hospital at UCLA, and Mattel Children's Hospital UCLA have produced a system of hospital care that is unparalleled in California. Ronald Reagan UCLA Medical Center is consistently ranked one of the top five hospitals in the nation and the best in the western United States by U.S. News & World Report, and the UCLA Medical Group has been ranked among the best in Southern California for four successive years by the Integrated Healthcare Association. UCLA physicians and hospitals will continue to be world leaders in the full range of care, from maintaining the health of families to the diagnosis and treatment of complex illnesses.